What our study suggests is something broader: GLP-1 drugs may also quiet what I call drug noise, the relentless craving that drives addiction across substances
In 2009, the FDA issued a warning letter to Bayer, after finding its Mirena promotions overstated the efficacy of the device, presented unsubstantiated claims, minimized the risks of Mirena, and used false and misleading presentations during in-home events touting the IUD
The evidence base for GLP-1 agonists in binge eating disorder remains preliminary, with most data coming from case reports, small case series, and secondary analyses rather than large randomized controlled trials specifically designed for BED
503B outsourcing facilities had until March 19
Practical Considerations Managing three different compounds requires organization and attention to detail